Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib
暂无分享,去创建一个
C. Peschel | J. Duyster | M. Sigl | C. Rummelt | N. Bubnoff | H. Menzel | Christian Peschel | Helge Dr Menzel